1Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol, 2002, 21:780- 788.
2McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension:the impact of epoprostenol therapy. Circulation ,2002,17 : 1477-1482.
3Austen WG, Morrow AG, Berry WB. Experimental studies of the surgical treatment of primary puhnonary hypertension. J Thorae Cardiovasc Surg, 1964, 48: 448-455.
4Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Hearl J, 1986, 55 : 449-458.
5Hopkins WE, Ochoa I.L, Richardson GW, et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant, 1996, 15:100-105.
6Sandoval J,Gaspar J, PulidoT, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol, 1998, 32:297-304.
7Stuart R, Emad D, Vallerie V, et al. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol, 1997,80:369-371.
8Kawaguchi AT, Kawaguchi Y, lshibashi-Ueda H, et al. Right-to-left interatrial shunt in rats with progressive pulmonary hypertension. J Thorac Cardiovasc Surg, 1993, 106:1072-1080.
9Ciarka A, Vachiery JL, Houssiere A, et ah Atrial septostomy decreases sympathetic overactivity in puhnonary arterial hypertension. Chest, 2007, 131:1831-1837.
10Rich S, Lain W. Atrial septostomy as palliative therapy for refractory primary puhnonary hypertension. Am J Cardiol, 1983, 51 : 1560-1561.
8Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance inadultcongenitalheartdisease: comparative severity, correlates, and prognostic implication. Circulation, 2005, 112:828-835.
9Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease:a description of six grades of structural changes in the pulmonary arteries with special reference to congenital heart defect. Circulation, 1985, 18:533-547.
10Reqitz-Zaqrosek V, Blomstrom Lundqvist C, Borqhi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnanlines on the management of cardiovascular Diseases during Pregnancy of the European Society of Cardiology(ESC). Eur Heart J, 2011, 32:3147-3197.
